Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Prasterone on Cardiometabolic Indicators in Perimenopausal Women
NCT07609043Phase 3Completed
- Sponsor
- Universidad de Guanajuato
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in cardiometabolic risk (CMR), sponsored by Universidad de Guanajuato. Started Jan 2020; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on NCT07609043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07609043.